Single Source for Continuation of the Integrated Islet Distribution Program U24 (Clinical Trial Not Allowed)
Awards up to $2,200,000 per recipient for others (see text field entitled "additional information on eligibility" for clarification), closing Sep 30, 2026.
In one sentence
Single Source for Continuation of the Integrated Islet Distribution Program U24 (Clinical Trial Not Allowed) awards up to $2,200,000 per recipient, open to others (see text field entitled "additional information on eligibility" for clarification), closing Sep 30, 2026.
- Program pool (total)
- $3,300,000Total across all awards in this programme. Not an amount any single applicant can receive.
- Award ceiling (per project)
- $2,200,000
- Award floor
- Not confirmed
- Typical award
- Not confirmed
- Deadline
- Sep 30, 2026
- Deadline type
- Fixed date
- Opens
- May 20, 2026
- Status
- Closing soon
- Eligible entities
- Others (see text field entitled "Additional Information on Eligibility" for clarification)
- Geography
- Not stated
- Matching funds
- Not confirmed
- Disbursement
- Not confirmed
- Application effort
- Not confirmed
- Use of funds
- islet resources for diabetes research · distribution of human islets to biomedical researchers
- Currency
- USD
How much money is available?
Two different figures govern a programme and they are not interchangeable. The programme pool is what the funder has allocated across every award it will make this cycle. The award ceiling is the most one applicant can be granted.
Who can apply?
Not confirmed
Source field: applicant size limitOnly the PI/PDs associated with the award issued under RFA-DK-20-509 to Beckman Research Institute/City of Hope is eligible to apply for this single source funding. Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/Foreign Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
We store the structured fields above. Clause-by-clause text from the guidelines is not connected for this record.When does it close?
What can the money be used for?
2 categorysThe source’s own spending categories, and what is not parsed.
These categories come from the source's own classification. A line-item cost table, where the programme publishes one, lives in the guidelines and is not parsed for this record.
Common questions
5 questionsEvery answer is a stored field from this record. Questions the source did not answer are not asked.
- How much can one applicant receive?
- Up to $2,200,000 per recipient.
- How much funding is available in total?
- $3,300,000 across the whole programme. This is the total the funder has allocated, not an amount any single applicant can receive.
- When is the application deadline?
- Sep 30, 2026.
- Who is eligible to apply?
- Others (see text field entitled "Additional Information on Eligibility" for clarification).
- What can the funding be used for?
- islet resources for diabetes research, distribution of human islets to biomedical researchers, as classified by the source.
AI summary of the source text
Optional. Every core field on this record is already above, free and complete.
AI summary of the source text
Studio reads this record’s stored eligibility and materials text and breaks it into separate points, each quoting the exact words it came from. It never writes application prose, never guesses at a field the source did not state, and never estimates anyone’s chances.
Included with Studio
Sign inThe official page governs. If the source and this record disagree, the source is correct — programmes change their terms between our checks, so confirm every figure above before you apply.